LARIMAR THERAPEUTICS, INC. (LRMR) Capital expenditures 2016–2025
LARIMAR THERAPEUTICS, INC. (LRMR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$91,000FY2025 · since FY2016: $660,000 → $91,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $91,000 | -82.3% |
| FY2024 | $515,000 | +214.0% |
| FY2023 | $164,000 | +64.0% |
| FY2022 | $100,000 | -70.0% |
| FY2021 | $333,000 | +437.1% |
| FY2020 | $62,000 | -25.3% |
| FY2019 | $83,000 | -23.1% |
| FY2018 | $108,000 | +96.4% |
| FY2017 | $55,000 | -91.7% |
| FY2016 | $660,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice